person · Reporting owner

Malik Rajiv

Disclosed activity across 2 companies

Tapewire entity: 82193
SEC CIK: 0001388111

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Viatris IncVTRS · Entity 3277	Director	March 06, 2025	March 10, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Viatris Inc

Report date March 06, 2025 · Filed March 10, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	23,660	Reported balance After 2025-03-06 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2025-03-06 · Grant · Acquired 23,660 · Balance 23,660 F1: As previously disclosed on October 20, 2023, the reporting person informed Viatris Inc. ("Viatris") of his intention to retire from his executive role with Viatris effective as of April 1, 2024 and agreed to remain a member of Viatris' Board of Directors. As a non-employee director, the reporting person is eligible to participate in Viatris' non-employee director compensation program. Represents restricted stock units (RSUs) granted for such service, consistent with the grants provided to Viatris' other non-employee directors. F2: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 6, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: As previously disclosed on October 20, 2023, the reporting person informed Viatris Inc. ("Viatris") of his intention to retire from his executive role with Viatris effective as of April 1, 2024 and agreed to remain a member of Viatris' Board of Directors. As a non-employee director, the reporting person is eligible to participate in Viatris' non-employee director compensation program. Represents restricted stock units (RSUs) granted for such service, consistent with the grants provided to Viatris' other non-employee directors.

F2: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 6, 2026.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Mylan II B.V.

Report date November 16, 2020 · Filed November 18, 2020

Section 16 reporting ended · disclosed 2020-11-18. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	0	Reported balance After 2020-11-16 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2020-11-16 · Disposition to issuer · Disposed 459,699 · Balance 0 F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2: 28,546 ordinary shares were returned to the reporting person's direct beneficial ownership on November 10, 2020 in the form of a scheduled annuity payment under the terms of the grantor retained annuity trust to which the reporting person initially contributed 100,000 ordinary shares on October 23, 2018 and 161,635 ordinary shares were returned to the reporting person's direct beneficial ownership on November 11, 2020 in the form of a scheduled annuity payment under the terms of the grantor retained annuity trust to which the reporting person initially contributed 250,000 ordinary shares on September 18, 2019. F3: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.
Ordinary SharesSEC Table I · non-derivative	IndirectBy Grantor Retained Annuity Trust	0	Reported balance After 2020-11-16 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2020-11-16 · Disposition to issuer · Disposed 88,365 · Balance 0 F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F3: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.
Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $55.84 · Expires 2024-03-05	Direct	0	Reported balance After 2020-11-16 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2020-11-16 · Disposition to issuer · Disposed 34,389 · Balance 0 F3: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F5: These options vested on March 5, 2017.
Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $50.66 · Expires 2025-11-17	Direct	0	Reported balance After 2020-11-16 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2020-11-16 · Disposition to issuer · Disposed 41,637 · Balance 0 F3: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F6: These options vested on March 4, 2018.
Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $46.27 · Expires 2026-02-17	Direct	0	Reported balance After 2020-11-16 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2020-11-16 · Disposition to issuer · Disposed 50,168 · Balance 0 F3: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F7: These options vested on February 17, 2019.
Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $45.18 · Expires 2027-03-03	Direct	0	Reported balance After 2020-11-16 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2020-11-16 · Disposition to issuer · Disposed 65,574 · Balance 0 F3: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F8: These options vested on March 3, 2020.
Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $40.97 · Expires 2028-03-02	Direct	0	Reported balance After 2020-11-16 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2020-11-16 · Disposition to issuer · Disposed 71,600 · Balance 0 F3: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F9: 23,867 of these options vested on March 2, 2019, 23,866 vested on March 2, 2020 and 23,867 will vest on March 2, 2021.
Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $27.45 · Expires 2029-03-01	Direct	0	Reported balance After 2020-11-16 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2020-11-16 · Disposition to issuer · Disposed 60,053 · Balance 0 F3: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F14: 20,018 of these options vested on March 2, 2020, 20,017 will vest on March 2, 2021 and 20,018 will vest on March 2, 2022.
Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $17.48 · Expires 2030-03-02	Direct	0	Reported balance After 2020-11-16 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2020-11-16 · Disposition to issuer · Disposed 84,871 · Balance 0 F3: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F17: 28,291 of these options will vest on March 2, 2021 and 28,290 will vest on each of March 2, 2022 and March 2, 2023.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2020-11-16 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2020-11-16 · Disposition to issuer · Disposed 14,645 · Balance 0 F9: 23,867 of these options vested on March 2, 2019, 23,866 vested on March 2, 2020 and 23,867 will vest on March 2, 2021. F10: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F11: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2020-11-16 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2020-11-16 · Disposition to issuer · Disposed 67,031 · Balance 0 F9: 23,867 of these options vested on March 2, 2019, 23,866 vested on March 2, 2020 and 23,867 will vest on March 2, 2021. F10: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F15: Each RSU represents the right to receive one ordinary share of Mylan. 33,515 of the RSUs will vest on March 2, 2021 and 33,516 will vest on March 2, 2022.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2020-11-16 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2020-11-16 · Disposition to issuer · Disposed 157,895 · Balance 0 F9: 23,867 of these options vested on March 2, 2019, 23,866 vested on March 2, 2020 and 23,867 will vest on March 2, 2021. F10: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F18: Each RSU represents the right to receive one ordinary share of Mylan. 52,632 of the RSUs will vest on March 2, 2021, 52,631 will vest on March 2, 2022 and 52,632 will vest on March 2, 2023.
Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	73,225	Reported balance After 2020-11-16 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2020-11-16 · Grant · Acquired 73,225 · Balance 73,225 F12: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination.
Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2020-11-16 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2020-11-16 · Disposition to issuer · Disposed 73,225 · Balance 0 F12: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F13: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination.
Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	125,684	Reported balance After 2020-11-16 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2020-11-16 · Grant · Acquired 125,684 · Balance 125,684 F16: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination.
Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2020-11-16 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2020-11-16 · Disposition to issuer · Disposed 125,684 · Balance 0 F12: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F13: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F16: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination.
Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	197,369	Reported balance After 2020-11-16 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2020-11-16 · Grant · Acquired 197,369 · Balance 197,369 F19: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination.
Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	0	Reported balance After 2020-11-16 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2020-11-16 · Disposition to issuer · Disposed 197,369 · Balance 0 F12: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination. F13: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination. F19: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination.

Filing footnotes · ownership attribution and instrument terms

F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax).

F2: 28,546 ordinary shares were returned to the reporting person's direct beneficial ownership on November 10, 2020 in the form of a scheduled annuity payment under the terms of the grantor retained annuity trust to which the reporting person initially contributed 100,000 ordinary shares on October 23, 2018 and 161,635 ordinary shares were returned to the reporting person's direct beneficial ownership on November 11, 2020 in the form of a scheduled annuity payment under the terms of the grantor retained annuity trust to which the reporting person initially contributed 250,000 ordinary shares on September 18, 2019.

F3: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.

F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F5: These options vested on March 5, 2017.

F6: These options vested on March 4, 2018.

F7: These options vested on February 17, 2019.

F8: These options vested on March 3, 2020.

F9: 23,867 of these options vested on March 2, 2019, 23,866 vested on March 2, 2020 and 23,867 will vest on March 2, 2021.

F10: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination.

F11: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021.

F12: Each performance restricted stock unit ("PRSU") represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2018, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination.

F13: Represents PRSUs of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms (other than no longer being subject to the performance-based vesting conditions) in connection with the Combination.

F14: 20,018 of these options vested on March 2, 2020, 20,017 will vest on March 2, 2021 and 20,018 will vest on March 2, 2022.

F15: Each RSU represents the right to receive one ordinary share of Mylan. 33,515 of the RSUs will vest on March 2, 2021 and 33,516 will vest on March 2, 2022.

F16: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 1, 2019, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination.

F17: 28,291 of these options will vest on March 2, 2021 and 28,290 will vest on each of March 2, 2022 and March 2, 2023.

F18: Each RSU represents the right to receive one ordinary share of Mylan. 52,632 of the RSUs will vest on March 2, 2021, 52,631 will vest on March 2, 2022 and 52,632 will vest on March 2, 2023.

F19: Each PRSU represents the right to receive one ordinary share of Mylan. The PRSUs were initially granted on March 2, 2020, subject to the attainment of previously established three-year performance goals and a vesting period. The performance goals were deemed satisfied at the target level in connection with the Combination.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 06, 2025 Filed Mar 10, 2025 18:00 UTC	Viatris Inc VTRS · Entity 3277	GrantRestricted Stock Units · Derivative	23,660	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-25-036585 · ownership.xml · derivative · entry 1 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,660 Underlying: Common Stock · 23,660 shares Expires not disclosed F1 · security: As previously disclosed on October 20, 2023, the reporting person informed Viatris Inc. ("Viatris") of his intention to retire from his executive role with Viatris effective as of April 1, 2024 and agreed to remain a member of Viatris' Board of Directors. As a non-employee director, the reporting person is eligible to participate in Viatris' non-employee director compensation program. Represents restricted stock units (RSUs) granted for such service, consistent with the grants provided to Viatris' other non-employee directors. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 6, 2026. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 6, 2026. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionPerformance Restricted Stock Units · Derivative	779,841	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · derivative · entry 20 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 779,841 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F19 · derivative.exercise_date: Each PRSU represents the right to receive one share of common stock of Viatris. The PRSUs were initially granted on March 4, 2022, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 4, 2025. F19 · derivative.expiration_date: Each PRSU represents the right to receive one share of common stock of Viatris. The PRSUs were initially granted on March 4, 2022, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 4, 2025. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	GrantPerformance Restricted Stock Units · Derivative	779,841	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · derivative · entry 19 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 779,841 Underlying: Common Stock · 779,841 shares Expires not disclosed F9 · security: As previously disclosed on October 20, 2023, the reporting person informed Viatris Inc. (Viatris) of his intention to retire from his executive role with Viatris effective as of April 1, 2024 and agreed to remain a member of Viatris' Board of Directors. Represents award granted for executive service. F18 · security: Amount includes DEUs that accrued with respect to the PRSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying PRSUs. Fractional shares with respect to such DEUs were rounded up pursuant to the terms of the PRSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. F18 · shares: Amount includes DEUs that accrued with respect to the PRSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying PRSUs. Fractional shares with respect to such DEUs were rounded up pursuant to the terms of the PRSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. F19 · derivative.exercise_date: Each PRSU represents the right to receive one share of common stock of Viatris. The PRSUs were initially granted on March 4, 2022, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 4, 2025. F19 · derivative.expiration_date: Each PRSU represents the right to receive one share of common stock of Viatris. The PRSUs were initially granted on March 4, 2022, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 4, 2025. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionDividend Equivalent Units · Derivative	601.6204	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · derivative · entry 18 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 601.6204 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · shares: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F17 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on April 2, 2024 and vested on the same schedule as the underlying RSUs. F17 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on April 2, 2024 and vested on the same schedule as the underlying RSUs. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionRestricted Stock Units · Derivative	18,845	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · derivative · entry 17 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,845 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · security: As previously disclosed on October 20, 2023, the reporting person informed Viatris of his intention to retire from his executive role with Viatris effective as of April 1, 2024 and agreed to remain a member of Viatris' Board of Directors. As a non-employee director, the reporting person is eligible to participate in Viatris' non-employee director compensation program. Represents RSUs granted for such service, consistent with the grants provided to Viatris' other non-employee directors. F16 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 4, 2025. F16 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 4, 2025. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionDividend Equivalent Units · Derivative	10,961.2736	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · derivative · entry 16 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,961.2736 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · shares: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F14 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs. F14 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionRestricted Stock Units · Derivative	82,353	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · derivative · entry 15 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82,353 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · security: As previously disclosed on October 20, 2023, the reporting person informed Viatris Inc. (Viatris) of his intention to retire from his executive role with Viatris effective as of April 1, 2024 and agreed to remain a member of Viatris' Board of Directors. Represents award granted for executive service. F13 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 82,353 of the RSUs granted on March 4, 2022 vested on each of March 4, 2023, March 4, 2024 and March 4, 2025. F13 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 82,353 of the RSUs granted on March 4, 2022 vested on each of March 4, 2023, March 4, 2024 and March 4, 2025. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	339,153	$9.37	$3,177,863.61	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · nonDerivative · entry 12 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,068,262 F8 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on March 4, 2022. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	779,841	$0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · nonDerivative · entry 11 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,407,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	602	$0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · nonDerivative · entry 10 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 627,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 17 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	18,845	$0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · nonDerivative · entry 9 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 626,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	4,768	$9.37	$44,676.16	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · nonDerivative · entry 8 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 608,127 F6 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 4, 2022. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	10,962	$0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · nonDerivative · entry 7 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 612,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 14 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	35,816	$9.37	$335,595.92	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · nonDerivative · entry 6 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 601,933 F4 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2022. Read SEC document
March 04, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	82,353	$0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · nonDerivative · entry 5 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 637,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 03, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionDividend Equivalent Units · Derivative	7,668.0912	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · derivative · entry 14 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,668 Underlying: Common Stock · 7,668.0912 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · shares: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F12 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 3, 2023 and vest on the same schedule as the underlying RSUs. F12 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 3, 2023 and vest on the same schedule as the underlying RSUs. F11 · balance_after: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document
March 03, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionRestricted Stock Units · Derivative	81,761	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · derivative · entry 13 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,761 Underlying: Common Stock · 81,761 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · security: As previously disclosed on October 20, 2023, the reporting person informed Viatris Inc. (Viatris) of his intention to retire from his executive role with Viatris effective as of April 1, 2024 and agreed to remain a member of Viatris' Board of Directors. Represents award granted for executive service. F10 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 81,762 of the RSUs granted on March 3, 2023 vested on March 3, 2024, 81,761 vested on March 3, 2025 and 81,761 will vest on March 3, 2026. F10 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 81,762 of the RSUs granted on March 3, 2023 vested on March 3, 2024, 81,761 vested on March 3, 2025 and 81,761 will vest on March 3, 2026. Read SEC document
March 03, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	3,336	$9.33	$31,124.88	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · nonDerivative · entry 4 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 555,396 F3 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 3, 2023. Read SEC document
March 03, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	7,669	$0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · nonDerivative · entry 3 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 558,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 12 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document
March 03, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	36,536	$9.33	$340,880.88	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · nonDerivative · entry 2 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 551,063 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 3, 2023. Read SEC document
March 03, 2025 Filed Mar 5, 2025 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	81,761	$0.00	$0.00	Disclosure SEC source: 0000950170-25-034004 · ownership.xml · nonDerivative · entry 1 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 587,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
September 12, 2024 Filed Sep 13, 2024 18:00 UTC	Viatris Inc VTRS · Entity 3277	SaleCommon Stock	139,681	$11.66	$1,628,163.64	Disclosure SEC source: 0000950170-24-106507 · ownership.xml · nonDerivative · entry 2 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 505,838 F2 · price: Represents the weighted average price of the reporting person's disposition of 139,681 shares of common stock in transactions ranging from $11.61 to $11.695. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. Read SEC document
September 12, 2024 Filed Sep 13, 2024 18:00 UTC	Viatris Inc VTRS · Entity 3277	SaleCommon Stock	60,319	$11.71	$706,552.64	Disclosure SEC source: 0000950170-24-106507 · ownership.xml · nonDerivative · entry 1 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Irrevocable Trust Disclosed balance after: 0 F1 · price: Represents the weighted average price of the irrevocable trust's disposition of 60,319 shares of common stock in transactions ranging from $11.71 to $11.715. The irrevocable trust is for the benefit of the reporting person's spouse and children and the reporting person's spouse is the trustee of the trust. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. Read SEC document
August 30, 2024 Filed Aug 30, 2024 18:16 UTC	Viatris Inc VTRS · Entity 3277	SaleCommon Stock	50,000	$12.00	$600,000.00	Disclosure SEC source: 0000950170-24-102480 · ownership.xml · nonDerivative · entry 2 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Irrevocable Trust Disclosed balance after: 60,319 Read SEC document
August 28, 2024 Filed Aug 30, 2024 18:16 UTC	Viatris Inc VTRS · Entity 3277	SaleCommon Stock	50,000	$11.90	$595,075.00	Disclosure SEC source: 0000950170-24-102480 · ownership.xml · nonDerivative · entry 1 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Irrevocable Trust Disclosed balance after: 110,319 F1 · price: Represents the weighted average price of the irrevocable trust's disposition of 50,000 shares of common stock in transactions ranging from $11.90 to $11.905. The irrevocable trust is for the benefit of the reporting person's spouse and children and the reporting person's spouse is the trustee of the trust. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. Read SEC document
August 23, 2024 Filed Aug 23, 2024 18:05 UTC	Viatris Inc VTRS · Entity 3277	SaleCommon Stock	100,000	$11.75	$1,175,100.00	Disclosure SEC source: 0000950170-24-100278 · ownership.xml · nonDerivative · entry 3 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Irrevocable Trust Disclosed balance after: 160,319 F3 · price: Represents the weighted average price of the irrevocable trust's disposition of 100,000 shares of common stock in transactions ranging from $11.75 to $11.755. The irrevocable trust is for the benefit of the reporting person's spouse and children and the reporting person's spouse is the trustee of the trust. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. Read SEC document
August 22, 2024 Filed Aug 23, 2024 18:05 UTC	Viatris Inc VTRS · Entity 3277	SaleCommon Stock	100,000	$11.73	$1,172,630.00	Disclosure SEC source: 0000950170-24-100278 · ownership.xml · nonDerivative · entry 2 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Irrevocable Trust Disclosed balance after: 260,319 F2 · price: Represents the weighted average price of the irrevocable trust's disposition of 100,000 shares of common stock in transactions ranging from $11.715 to $11.735. The irrevocable trust is for the benefit of the reporting person's spouse and children and the reporting person's spouse is the trustee of the trust. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. Read SEC document
August 21, 2024 Filed Aug 23, 2024 18:05 UTC	Viatris Inc VTRS · Entity 3277	SaleCommon Stock	100,000	$11.75	$1,175,260.00	Disclosure SEC source: 0000950170-24-100278 · ownership.xml · nonDerivative · entry 1 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Irrevocable Trust Disclosed balance after: 360,319 F1 · price: Represents the weighted average price of the irrevocable trust's disposition of 100,000 shares of common stock in transactions ranging from $11.75 to $11.76. The irrevocable trust is for the benefit of the reporting person's spouse and children and the reporting person's spouse is the trustee of the trust. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. Read SEC document
June 14, 2024 Filed Jun 17, 2024 18:00 UTC	Viatris Inc VTRS · Entity 3277	SaleCommon Stock	264,300	$10.18	$2,690,283.27	Disclosure SEC source: 0000950170-24-074441 · ownership.xml · nonDerivative · entry 2 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 645,519 F2 · price: Represents the weighted average price of the reporting person's disposition of 264,300 shares of common stock in transactions ranging from $10.17 to $10.205. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. Read SEC document
June 13, 2024 Filed Jun 17, 2024 18:00 UTC	Viatris Inc VTRS · Entity 3277	SaleCommon Stock	85,660	$10.52	$900,740.60	Disclosure SEC source: 0000950170-24-074441 · ownership.xml · nonDerivative · entry 1 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 909,819 F1 · price: Represents the weighted average price of the reporting person's disposition of 85,660 shares of common stock in transactions ranging from $10.50 to $10.525. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. Read SEC document
April 02, 2024 Filed Apr 4, 2024 18:00 UTC	Viatris Inc VTRS · Entity 3277	GrantRestricted Stock Units · Derivative	18,845	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-24-041927 · ownership.xml · derivative · entry 1 Malik Rajiv · CIK 0001388111 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,845 Underlying: Common Stock · 18,845 shares Expires not disclosed F1 · security: As previously disclosed on October 20, 2023, the reporting person informed Viatris Inc. ("Viatris") of his intention to retire from his executive role with Viatris effective as of April 1, 2024 and agreed to remain a member of Viatris' Board of Directors. As a non-employee director, the reporting person is eligible to participate in Viatris' non-employee director compensation program. Represents restricted stock units (RSUs) granted for such service, consistent with the grants provided to Viatris' other non-employee directors. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2025. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2025. Read SEC document
March 04, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionDividend Equivalent Units · Derivative	7,160.2231	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · derivative · entry 23 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,161 Underlying: Common Stock · 7,160.2231 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · shares: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F19 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs. F19 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs. F14 · balance_after: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document
March 04, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionRestricted Stock Units · Derivative	82,353	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · derivative · entry 22 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,353 Underlying: Common Stock · 82,353 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F18 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 82,353 of the RSUs granted on March 4, 2022 vested on each of March 4, 2023 and March 4, 2024 and 82,353 will vest on March 4, 2025. F18 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 82,353 of the RSUs granted on March 4, 2022 vested on each of March 4, 2023 and March 4, 2024 and 82,353 will vest on March 4, 2025. Read SEC document
March 04, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	3,115	$12.36	$38,501.40	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · nonDerivative · entry 14 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 995,479 F10 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 4, 2022. Read SEC document
March 04, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	7,161	$0.00	$0.00	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · nonDerivative · entry 13 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 998,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 19 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document
March 04, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	35,816	$12.36	$442,685.76	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · nonDerivative · entry 12 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 991,433 F8 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2022. Read SEC document
March 04, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	82,353	$0.00	$0.00	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · nonDerivative · entry 11 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,027,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 03, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionDividend Equivalent Units · Derivative	4,025.2074	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · derivative · entry 21 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,052 Underlying: Common Stock · 4,025.2074 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · shares: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F17 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 3, 2023 and vest on the same schedule as the underlying RSUs. F17 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 3, 2023 and vest on the same schedule as the underlying RSUs. F14 · balance_after: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. Read SEC document
March 03, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionRestricted Stock Units · Derivative	81,762	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · derivative · entry 20 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,522 Underlying: Common Stock · 81,762 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F16 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 81,762 of the RSUs granted on March 3, 2023 vested on March 3, 2024, and 81,761 will vest on each of March 3, 2025 and March 3, 2026. F16 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 81,762 of the RSUs granted on March 3, 2023 vested on March 3, 2024, and 81,761 will vest on each of March 3, 2025 and March 3, 2026. Read SEC document
March 03, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	1,751	$12.59	$22,045.09	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · nonDerivative · entry 10 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 944,896 F7 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 3, 2023. Read SEC document
March 03, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	4,026	$0.00	$0.00	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · nonDerivative · entry 9 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 946,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 17 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document
March 03, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	35,559	$12.59	$447,687.81	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · nonDerivative · entry 8 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 942,621 F5 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 3, 2023. Read SEC document
March 03, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	81,762	$0.00	$0.00	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · nonDerivative · entry 7 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 978,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 02, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionDividend Equivalent Units · Derivative	8,882.3848	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · derivative · entry 19 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,882.3848 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · shares: Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. F15 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F15 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document
March 02, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionRestricted Stock Units · Derivative	67,180	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · derivative · entry 18 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 67,180 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 67,180 of the RSUs granted on March 2, 2021 vested on each of March 2, 2022, March 2, 2023 and March 2, 2024. F13 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 67,180 of the RSUs granted on March 2, 2021 vested on each of March 2, 2022, March 2, 2023 and March 2, 2024. Read SEC document
March 02, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionPerformance Restricted Stock Units · Derivative	357,353	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · derivative · entry 17 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 357,353 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: Each PRSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). The PRSUs were initially granted on March 2, 2021, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 2, 2024. F12 · derivative.expiration_date: Each PRSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). The PRSUs were initially granted on March 2, 2021, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 2, 2024. Read SEC document
March 02, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	GrantPerformance Restricted Stock Units · Derivative	357,353	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · derivative · entry 16 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 357,353 Underlying: Common Stock · 357,353 shares Expires not disclosed F11 · security: Amount includes DEUs that accrued with respect to the PRSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying PRSUs. Fractional shares with respect to such DEUs were rounded up pursuant to the terms of the PRSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. F11 · shares: Amount includes DEUs that accrued with respect to the PRSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying PRSUs. Fractional shares with respect to such DEUs were rounded up pursuant to the terms of the PRSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. F12 · derivative.exercise_date: Each PRSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). The PRSUs were initially granted on March 2, 2021, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 2, 2024. F12 · derivative.expiration_date: Each PRSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). The PRSUs were initially granted on March 2, 2021, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs vested on March 2, 2024. Read SEC document
March 02, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	3,864	$12.59	$48,647.76	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · nonDerivative · entry 6 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 896,418 F4 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 2, 2021. Read SEC document
March 02, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	8,883	$0.00	$0.00	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · nonDerivative · entry 5 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 15 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document
March 02, 2024 Filed Mar 5, 2024 20:09 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	29,217	$12.59	$367,842.03	Disclosure SEC source: 0000950170-24-026630 · ownership.xml · nonDerivative · entry 4 Malik Rajiv · CIK 0001388111 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 891,399 F2 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2021. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.